Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Avalo Therapeutics Inc banner

Avalo Therapeutics Inc
NASDAQ:AVTX

Watchlist Manager
Avalo Therapeutics Inc Logo
Avalo Therapeutics Inc
NASDAQ:AVTX
Watchlist
Price: 13.1 USD -3.75% Market Closed
Market Cap: $688.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

AVTX Price Targets Summary
Avalo Therapeutics Inc

Wall Street analysts forecast AVTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVTX is 47.94 USD with a low forecast of 35.35 USD and a high forecast of 65.1 USD.

AVTX Lowest Forecast
35.35 USD
170% Upside
AVTX Average Forecast
47.94 USD
266% Upside
AVTX Highest Forecast
65.1 USD
397% Upside
Lowest Forecast
Price Target
35.35 USD
170% Upside
Average Forecast
Price Target
47.94 USD
266% Upside
Highest Forecast
Price Target
65.1 USD
397% Upside
Avalo Therapeutics Inc Competitors:
Price Targets
PRQR
ProQR Therapeutics NV
512% Upside
CASY
Caseys General Stores Inc
0% Downside
NYXH
Nyxoah SA
258% Upside
UFPT
UFP Technologies Inc
48% Upside
PRQR
ProQR Therapeutics NV
512% Upside
CASY
Caseys General Stores Inc
0% Downside
NYXH
Nyxoah SA
258% Upside
UFPT
UFP Technologies Inc
48% Upside

Revenue
Forecast

-2% / Year
Past Growth
227% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
-2% / Year
Past Growth
227% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Avalo Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Avalo Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss

What are analyst estimates?

See Also

Summary
AVTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AVTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AVTX stock valuation using valuation multiples.
Wall St Estimates
AVTX price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AVTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Avalo Therapeutics Inc listings:
F • EUR
C6K
 F • EUR
C6K0
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AVTX's stock price target?
Price Target
47.94 USD

According to Wall Street analysts, the average 1-year price target for AVTX is 47.94 USD with a low forecast of 35.35 USD and a high forecast of 65.1 USD.

What is the Revenue forecast for Avalo Therapeutics Inc?
Projected CAGR
227%

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 227%.

Back to Top
ALPHA SPREAD
Follow us
Join 341,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett